Discover
ALLR
Allarity Therapeutics, Inc.
0.99
2 x 0.76
2 x 1.33
bid
ask
+
0.01
0.82%
2 @ 05:45 PM
1.01 +0.02 (2.01%)
| Ytd | -8.33% | |
| 1y | -43.75% |
0.99
day range
1.04
0.81
52 week range
1.77
| Open | 0.99 | Prev Close | 0.98 | Low | 0.99 | High | 1.04 | Mkt Cap | 15.75M |
| Vol | 97.23K | Avg Vol | 90.75K | EPS | -0.80 | P/E | N/A | Forward P/E | -0.02 |
| Beta | 0.29 | Short Ratio | 0.30 | Inst. Own | 2.21% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 1.25 | 200-d Avg | 1.24 | 1yr Est | 5.00 |
| Income Statement | |||
| Operating Expenses | 2.67M | ||
| Research and Development Expense | 1.35M | ||
| Selling, General and Administrative Expense | 1.33M | ||
| Operating Income | -2.67M | ||
| Interest Expense | 719.00K | ||
| Net Income | -3.40M | ||
| Net Income Common Stock | -3.40M | ||
| Net Income Common Stock (USD) | -3.40M | ||
| Consolidated Income | -3.40M | ||
| Earnings per Basic Share | -0.21 | ||
| Earnings per Basic Share (USD) | -0.21 | ||
| Earnings per Diluted Share | -0.21 | ||
| Earning Before Interest & Taxes (EBIT) | -2.69M | ||
| Earning Before Interest & Taxes (USD) | -2.69M | ||
| Weighted Average Shares | 15.91M | ||
| Weighted Average Shares Diluted | 15.91M | ||
| Balance Sheet | |||
| Cash and Equivalents | 26.98M | ||
| Cash and Equivalents (USD) | 26.98M | ||
| Current Assets | 31.73M | ||
| Property, Plant & Equipment Net | 386.00K | ||
| Total Assets | 32.12M | ||
| Debt Current | 22.29M | ||
| Total Debt | 22.29M | ||
| Current Liabilities | 28.58M | ||
| Total Liabilities | 28.58M | ||
| Accumulated Retained Earnings (Deficit) | -136.35M | ||
| Accumulated Other Comprehensive Income | -1.35M | ||
| Shareholders Equity | 3.54M | ||
| Shareholders Equity (USD) | 3.54M | ||
| Assets Non-Current | 386.00K | ||
| Total Debt (USD) | 22.29M | ||
| Trade and Non-Trade Payables | 4.11M | ||
| Tax Assets | 1.31M | ||
| Tax Liabilities | 81.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 34.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.89M | ||
| Net Cash Flow from Operations | -2.56M | ||
| Effect of Exchange Rate Changes on Cash | -267.00K | ||
| Share Based Compensation | 288.00K | ||